文献速递中毒与环境急症重症综合管理与镇静镇痛

单剂苯巴比妥联合症状触发劳拉西泮治疗酒精戒断

Single dose phenobarbital in addition to symptom-triggered lorazepam in alcohol withdrawal.
PubMed 文献 · Am J Emerg Med · 2019-01-30
一句话结论急诊酒精戒断患者住院首日加用单剂胃肠外苯巴比妥,与仅用症状触发劳拉西泮相比,3天内出院人数更多(9例 vs 2例,P<0.05)。

本研究为回顾性病历审查,纳入急诊就诊的中重度酒精戒断成年患者,住院首日经酒精戒断医嘱套餐接受至少4 mg劳拉西泮。比较首日接受单剂胃肠外苯巴比妥者与未接受者的结局。两组每日劳拉西泮需求量、出院去向、住院时长及每日最大CIWA-Ar评分中位数均无统计学显著差异。苯巴比妥组3天内出院人数显著多于劳拉西泮组(9例 vs 2例,P<0.05)。苯巴比妥组未观察到不良事件。

要点

  • 急诊中重度酒精戒断成人患者,住院首日加用单剂胃肠外苯巴比妥者3天内出院9例,仅用劳拉西泮者2例(P<0.05)。
  • 两组每日劳拉西泮需求量、出院去向、住院时长及每日最大CIWA-Ar评分中位数均无统计学显著差异。
  • 苯巴比妥组未观察到不良事件;劳拉西泮组2例插管、1例酒精戒断性谵妄、无癫痫发作。
  • 作者建议急诊医生可考虑对酒精戒断患者住院首日给予一剂胃肠外苯巴比妥。

适用人群与场景

  • 急诊就诊的中重度酒精戒断症状成年患者。
  • 纳入条件:住院首日经医院酒精戒断医嘱套餐接受至少4 mg劳拉西泮。

诊断标准与关键阈值

  • 使用每日最大CIWA-Ar评分评估戒断严重程度。

处置流程与药物剂量

  • 住院首日经医院酒精戒断医嘱套餐给予至少4 mg劳拉西泮,按症状触发。
  • 苯巴比妥组在住院首日加用单剂胃肠外苯巴比妥。

研究设计与关键结果

  • 回顾性病历审查;苯巴比妥组40例,仅劳拉西泮组38例。
  • 每日劳拉西泮需求量、出院去向、住院时长及每日最大CIWA-Ar评分中位数两组无统计学显著差异。
  • 3天内出院:苯巴比妥组9例 vs 仅劳拉西泮组2例,P<0.05。
  • 仅劳拉西泮组2例插管、1例酒精戒断性谵妄、无癫痫发作;苯巴比妥组无不良事件。

证据类型、等级与局限

  • 证据类型:回顾性病历审查。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者建议急诊医生可考虑对急诊就诊的酒精戒断患者住院首日给予一剂胃肠外苯巴比妥,以增加3天内出院可能。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: The purpose of this study was to evaluate the safety and efficacy of a single parenteral dose of phenobarbital in addition to symptom-triggered lorazepam for the acute management of alcohol withdrawal syndrome (AWS).

METHODS: This was a retrospective chart review of adult patients who presented to the Emergency Department with moderate or severe symptoms of alcohol withdrawal. Patients were included if they received at least 4 mg of lorazepam through the hospital's Alcohol Withdrawal Order Set on hospital day one. Patients who received a single parenteral dose of phenobarbital on hospital day one were compared to those who did not.

RESULTS: Forty patients received phenobarbital and 38 patients received lorazepam only. Median daily lorazepam requirements, disposition, hospital length of stay, and median maximum daily CIWA-Ar scores were not statistically significant different between the groups. Significantly more patients in the phenobarbital group were discharged within three days in comparison to the lorazepam only group (9 patients vs. 2 patients, respectively, p < 0.05). In the lorazepam only group, two patients were intubated, one patient had delirium tremens, and no patients seized. In the phenobarbital group no adverse events were observed.

CONCLUSIONS: More patients were discharged within three days if they received a single parenteral dose of phenobarbital on hospital day one, in addition to symptom-triggered lorazepam for the acute management of AWS. Emergency Medicine physicians should consider ordering one parenteral phenobarbital dose on hospital day one to patients presenting with AWS.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Ibarra F. Single dose phenobarbital in addition to symptom-triggered lorazepam in alcohol withdrawal. Am J Emerg Med. 2019. PMID: 30744913. doi:10.1016/j.ajem.2019.01.053

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。